Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Am J Hematol ; 98(12): E383-E386, 2023 12.
Article in English | MEDLINE | ID: mdl-37800361

ABSTRACT

THC triggers a pronounced entry of Ca2+ , which may be deleterious, into sickle cell red blood cells via activation of the TRPV2 channel.


Subject(s)
Anemia, Sickle Cell , Dronabinol , Humans , Dronabinol/adverse effects , Erythrocytes , Anemia, Sickle Cell/drug therapy
2.
Front Physiol ; 14: 1222983, 2023.
Article in English | MEDLINE | ID: mdl-37492641

ABSTRACT

PIEZO1 is a mechanosensitive non-selective cation channel, present in many cell types including Red Blood Cells (RBCs). Together with the Gárdos channel, PIEZO1 forms in RBCs a tandem that participates in the rapid adjustment of the cell volume. The pharmacology allowing functional studies of the roles of PIEZO1 has only recently been developed, with Yoda1 as a widely used PIEZO1 agonist. In 2018, Yoda1 analogues were developed, as a step towards an improved understanding of PIEZO1 roles and functions. Among these, Dooku1 was the most promising antagonist of Yoda1-induced effects, without having any ability to activate PIEZO1 channels. Since then, Dooku1 has been used in various cell types to antagonize Yoda1 effects. In the present study using RBCs, Dooku1 shows an apparent IC50 on Yoda1 effects of 90.7 µM, one order of magnitude above the previously reported data on other cell types. Unexpectedly, it was able, by itself, to produce entry of calcium sufficient to trigger Gárdos channel activation. Moreover, Dooku1 evoked a rise in intracellular sodium concentrations, suggesting that it targets a non-selective cation channel. Dooku1 effects were abolished upon using GsMTx4, a known mechanosensitive channel blocker, indicating that Dooku1 likely targets PIEZO1. Our observations lead to the conclusion that Dooku1 behaves as a PIEZO1 agonist in the RBC membrane, similarly to Yoda1 but with a lower potency. Taken together, these results show that the pharmacology of PIEZO1 in RBCs must be interpreted with care especially due to the unique characteristics of RBC membrane and associated cytoskeleton.

3.
Nanoscale ; 15(4): 1739-1753, 2023 Jan 27.
Article in English | MEDLINE | ID: mdl-36598381

ABSTRACT

2D ultrathin metal nanostructures are emerging materials displaying distinct physical and chemical properties compared to their analogues of different dimensionalities. Nanosheets of fcc metals are intriguing, as their crystal structure does not favour a 2D configuration. Thanks to their increased surface-to-volume ratios and the optimal exposure of low-coordinated sites, 2D metal nanostructures can be advantageously exploited in catalysis. Synthesis approaches to ultrathin nanosheets of pure platinum are scarce compared to other noble metals and to Pt-based alloys. Here, we present the selective synthesis of Pt ultrathin nansosheets by a simple seeded-growth method. The most crucial point in our approach is the selective synthesis of Pt seeds comprising planar defects, a main driving force for the 2D growth of metals with fcc structure. Defect engineering is employed here, not in order to disintegrate, but for conserving the defect comprising seeds. This is achieved by in situ elimination of the principal etching agent, chloride, which is present in the PtCl2 precursor. As a result of etching suppression, twinned nuclei, that are selectively formed during the early stage of nucleation, survive and grow to multipods comprising planar defects. Using the twinned multipods as seeds for the subsequent 2D overgrowth of Pt from Pt(acac)2 yields ultrathin dendritic nanosheets, in which the planar defects are conserved. Using phenylacetylene hydrogenation as a model reaction of selective hydrogenation, we compared the performance of Pt nanosheets to that of a commercial Pt/C catalyst. The Pt nanosheets show better stability and much higher selectivity to styrene than the commercial Pt/C catalyst for comparable activity.

4.
Front Physiol ; 12: 743094, 2021.
Article in English | MEDLINE | ID: mdl-34707512

ABSTRACT

Handbooks of physiology state that the strategy adopted by red blood cells (RBCs) to preserve cell volume is to maintain membrane permeability for cations at its minimum. However, enhanced cation permeability can be measured and observed in specific physiological and pathophysiological situations such as in vivo senescence, storage at low temperature, sickle cell anemia and many other genetic defects affecting transporters, membrane or cytoskeletal proteins. Among cation pathways, cation channels are able to dissipate rapidly the gradients that are built and maintained by the sodium and calcium pumps. These situations are very well-documented but a mechanistic understanding of complex electrophysiological events underlying ion transports is still lacking. In addition, non-selective cation (NSC) channels present in the RBC membrane have proven difficult to molecular identification and functional characterization. For instance, NSC channel activity can be elicited by Low Ionic Strength conditions (LIS): the associated change in membrane potential triggers its opening in a voltage dependent manner. But, whereas this depolarizing media produces a spectacular activation of NSC channel, Gárdos channel-evoked hyperpolarization's have been shown to induce sodium entry through a pathway thought to be conductive and termed P cat. Using the CCCP method, which allows to follow fast changes in membrane potential, we show here (i) that hyperpolarization elicited by Gárdos channel activation triggers sodium entry through a conductive pathway, (ii) that chloride conductance inhibition unveils such conductive cationic conductance, (iii) that the use of the specific chloride conductance inhibitor NS3623 (a derivative of Neurosearch compound NS1652), at concentrations above what is needed for full anion channel block, potentiates the non-selective cation conductance. These results indicate that a non-selective cation channel is likely activated by the changes in the driving force for cations rather than a voltage dependence mechanism per se.

5.
Nanoscale ; 13(19): 8931-8939, 2021 May 20.
Article in English | MEDLINE | ID: mdl-33956009

ABSTRACT

Production of formate via CO2/bicarbonate hydrogenation using cheap metal-based heterogeneous catalysts is attractive. Herein, we report the organometallic synthesis of a foam-like Ni@Ni(OH)2 composite nanomaterial which exhibited remarkable air stability and over 2 times higher catalytic activity than commercial RANEY® Ni catalyst in formate synthesis. Formate generation was achieved with an optimal rate of 6.0 mmol gcat-1 h-1 at 100 °C, a significantly lower operation temperature compared to the 200-260 °C reported in the literature. Deep characterization evidenced that this nanomaterial was made of an amorphous Ni(OH)2 phase covering metallic Ni sites; a core-shell structure which is crucial for the stability of the catalyst. The adsorption of bicarbonates onto the Ni@Ni(OH)2 catalyst was found to be a kinetically relevant step in the reaction, and the Ni-Ni(OH)2 interface was found to be beneficial for both CO2 and H2 activation thanks to a cooperative effect. Our findings emphasize the underestimated potential of Ni-based catalysts in CO2 hydrogenation to formate, indicating a viable strategy to develop stable, cheap metal catalysts for greener catalytic applications.

7.
Nanoscale Adv ; 3(15): 4471-4481, 2021 Jul 27.
Article in English | MEDLINE | ID: mdl-36133455

ABSTRACT

To shed light on the factors governing the stability and surface properties of iron nanoparticles, a series of iron nanoparticles has been produced by hydrogenation of two different iron amido complexes: the bis[bis(trimethylsilyl)amido] Fe(ii), [Fe(N(SiMe3)2)2]2, and the bis(diphenylamido) Fe(ii), [Fe(NPh2)2]. Nanostructured materials of bcc structure, or nanoparticles displaying average sizes below 3 nm and a polytetrahedral structure, have been obtained. Depending on the synthesis conditions, the magnetization of the nanoparticles was either significantly lower than that of bulk iron, or much higher as for clusters elaborated under high vacuum conditions. Unexpectedly, hydrogenation of aromatic groups of the ligands of the [Fe(NPh2)2] precursor has been observed in some cases. Confrontation of the experimental results with DFT calculations made on polytetrahedral Fe91 model clusters bearing hydrides, amido and/or amine ligands at their surface, has shown that amido ligands can play a key role in the stabilisation of the nanoparticles in solution while the hydride surface coverage governs their surface magnetic properties. This study indicates that magnetic measurements give valuable indicators of the surface properties of iron nanoparticles in this size range, and beyond, of their potential reactivity.

10.
Elife ; 82019 01 15.
Article in English | MEDLINE | ID: mdl-30644818

ABSTRACT

Three amino acid loop extension homeodomain transcription factors (TALE HD TFs) act as life cycle regulators in green algae and land plants. In mosses these regulators are required for the deployment of the sporophyte developmental program. We demonstrate that mutations in either of two TALE HD TF genes, OUROBOROS or SAMSARA, in the brown alga Ectocarpus result in conversion of the sporophyte generation into a gametophyte. The OUROBOROS and SAMSARA proteins heterodimerise in a similar manner to TALE HD TF life cycle regulators in the green lineage. These observations demonstrate that TALE-HD-TF-based life cycle regulation systems have an extremely ancient origin, and that these systems have been independently recruited to regulate sporophyte developmental programs in at least two different complex multicellular eukaryotic supergroups, Archaeplastida and Chromalveolata.


Subject(s)
Embryophyta/growth & development , Embryophyta/metabolism , Homeodomain Proteins/metabolism , Phaeophyceae/growth & development , Phaeophyceae/metabolism , Plant Proteins/metabolism , Amino Acid Sequence , Embryophyta/genetics , Evolution, Molecular , Gene Expression Regulation, Plant , Homeodomain Proteins/chemistry , Homeodomain Proteins/genetics , Mutation/genetics , Phaeophyceae/genetics , Phenotype , Protein Binding , Protein Domains , RNA, Messenger/genetics , RNA, Messenger/metabolism , Transcription Factors/chemistry , Transcription Factors/genetics
11.
Nanoscale ; 10(48): 22730-22736, 2018 Dec 13.
Article in English | MEDLINE | ID: mdl-30500037

ABSTRACT

Supported nanocrystals of original shapes are highly desirable for the development of optimized catalysts; however, conventional methods for the preparation of supported catalysts do not allow shape control. In this work, we have synthesized concave platinum nanocubes exposing {110} crystallographic facets at 20 °C. In the presence of a crystallographically oriented Pt(111) support in the reaction medium, the concave nanocubes grow epitaxially on the support, producing macroscopic nanostructured surfaces. Higher reaction temperature produces a mixture of different nanostructures in solution; however, only the nanostructures growing along the 111 direction are obtained on the Pt(111) support. Therefore, the oriented surface acts as a template for a selective immobilization of specific nanostructures out of a mixture, which can be regarded as an "epitaxial resolution" of an inhomogeneous mixture of nanocrystals. Thus, a judicious choice of the support crystallographic orientation may allow the isolation of original nanostructures that cannot be obtained in a pure form.

12.
Angew Chem Int Ed Engl ; 57(33): 10579-10583, 2018 Aug 13.
Article in English | MEDLINE | ID: mdl-29893037

ABSTRACT

The Fischer-Tropsch synthesis (FTS) is a structure-sensitive exothermic reaction that enables catalytic transformation of syngas to high quality liquid fuels. Now, monolithic cobalt-based heterogeneous catalysts were elaborated through a wet chemistry approach that allows control over nanocrystal shape and crystallographic phase, while at the same time enables heat management. Copper and nickel foams have been employed as supports for the epitaxial growth of hcp-Co nanowires directly from a solution containing a coordination compound of cobalt and stabilizing ligands. The Co/Cufoam catalyst was tested for Fischer-Tropsch synthesis in a fixed-bed reactor, showing stability and significantly superior activity and selectivity towards C5+ compared to a Co/SiO2 -Al2 O3 reference catalyst under the same conditions.

13.
Nat Commun ; 9(1): 1841, 2018 05 04.
Article in English | MEDLINE | ID: mdl-29728567

ABSTRACT

In the originally published version of this Article, the authors Sai-Juan Chen and Zhu Chen were incorrectly listed as being affiliated with 'University Paris Diderot, Sorbonne Paris Cité, INSERM U944, CNRS UMR7212, Equipe labellisée LNCC, Hôpital St. Louis 1, Paris 75475, France', and the affiliation 'Institute of Health Sciences, Shanghai Institutes for Biological Sciences and Graduate School, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China' was inadvertently omitted. These errors have now been corrected in both the PDF and HTML versions of the Article.

14.
Nat Commun ; 9(1): 1277, 2018 03 29.
Article in English | MEDLINE | ID: mdl-29599493

ABSTRACT

ProMyelocyticLeukemia nuclear bodies (PML NBs) are stress-regulated domains directly implicated in acute promyelocytic leukemia eradication. Most TRIM family members bind ubiquitin E2s and many acquire ligase activity upon RING dimerization. In contrast, PML binds UBC9, the SUMO E2 enzyme. Here, using X-ray crystallography and SAXS characterization, we demonstrate that PML RING tetramerizes through highly conserved PML-specific sequences, which are required for NB assembly and PML sumoylation. Conserved residues implicated in RING dimerization of other TRIMs also contribute to PML tetramer stability. Wild-type PML rescues the ability of some RING mutants to form NBs as well as their sumoylation. Impaired RING tetramerization abolishes PML/RARA-driven leukemogenesis in vivo and arsenic-induced differentiation ex vivo. Our studies thus identify RING tetramerization as a key step in the NB macro-molecular scaffolding. They suggest that higher order RING interactions allow efficient UBC9 recruitment and thus change the biochemical nature of TRIM-facilitated post-translational modifications.


Subject(s)
Nuclear Proteins/metabolism , Promyelocytic Leukemia Protein/metabolism , Protein Multimerization , Ubiquitin-Conjugating Enzymes/metabolism , Animals , Cell Line , Crystallography, X-Ray , Humans , Leukemia, Promyelocytic, Acute/pathology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Multiprotein Complexes/metabolism , Protein Folding , Protein Processing, Post-Translational , Small Ubiquitin-Related Modifier Proteins/metabolism , Sumoylation , Ubiquitin-Protein Ligases/metabolism
15.
Sci Signal ; 9(440): tc1, 2016 08 09.
Article in English | MEDLINE | ID: mdl-27507651

ABSTRACT

Fasci et al proposed that a SENP1-mediated switch from SUMO2 to SUMO1 conjugation on Lys(65) in promyelocytic leukemia protein (PML) is required for arsenic-induced PML degradation, the basis for the antileukemic activity of arsenic. We found that PML or PML/RARA (retinoic acid receptor α) mutants that cannot be SUMO-conjugated on this specific site nevertheless underwent immediate arsenic-triggered SUMO modification. Moreover, these mutants were efficiently degraded in cells and even in vivo, demonstrating that SUMOylation of Lys(65) was dispensable for arsenic response. The existence and putative role of a SUMO switch on PML should thus be reassessed.


Subject(s)
Arsenic , Nuclear Proteins/genetics , Promyelocytic Leukemia Protein , Tumor Suppressor Proteins/genetics , Ubiquitination
16.
J Am Chem Soc ; 138(27): 8422-31, 2016 07 13.
Article in English | MEDLINE | ID: mdl-27300493

ABSTRACT

The molecular and ensemble dynamics for the growth of hierarchical supercrystals of cobalt nanorods have been studied by in situ tandem X-ray absorption spectroscopy-small-angle X-ray scattering (XAS-SAXS). The supercrystals were obtained by reducing a Co(II) precursor under H2 in the presence of a long-chain amine and a long-chain carboxylic acid. Complementary time-dependent ex situ TEM studies were also performed. The experimental data provide critical insights into the nanorod growth mechanism and unequivocal evidence for a concerted growth-organization process. Nanorod formation involves cobalt nucleation, a fast atom-by-atom anisotropic growth, and a slower oriented attachment process that continues well after cobalt reduction is complete. Smectic-like ordering of the nanorods appears very early in the process, as soon as nanoparticle elongation appears, and nanorod growth takes place inside organized superlattices, which can be regarded as mesocrystals.

17.
Blood ; 124(25): 3772-80, 2014 Dec 11.
Article in English | MEDLINE | ID: mdl-25258343

ABSTRACT

PML/RARA, a potent transcriptional inhibitor of nuclear receptor signaling, represses myeloid differentiation genes and drives acute promyelocytic leukemia (APL). Association of the retinoid X receptor-α (RXRA) coreceptor to PML/RARA is required for transformation, with RXRA promoting its efficient DNA binding. APL is exquisitely sensitive to retinoic acid (RA) and arsenic trioxide (arsenic), which both trigger cell differentiation in vivo. Whereas RA elicits transcriptional activation of PML/RARA targets, how arsenic triggers differentiation remains unclear. Here we demonstrate that extinction of PML/RARA triggers terminal differentiation in vivo. Similarly, ablation of retinoid X receptors loosens PML/RARA DNA binding, inducing terminal differentiation of APL cells ex vivo or in vivo. RXRA sumoylation directly contributes to PML/RARA-dependent transformation ex vivo, presumably by enhancing transcriptional repression. Thus, APL differentiation is a default program triggered by clearance of PML/RARA-bound promoters, rather than obligatory active transcriptional activation, explaining how arsenic elicits APL maturation through PML/RARA degradation.


Subject(s)
Cell Differentiation/genetics , Leukemia, Promyelocytic, Acute/genetics , Oncogene Proteins, Fusion/genetics , Promoter Regions, Genetic/genetics , Animals , Antineoplastic Agents/pharmacology , Arsenic Trioxide , Arsenicals/pharmacology , COS Cells , Cell Line, Tumor , Cell Transformation, Neoplastic/genetics , Cells, Cultured , Chlorocebus aethiops , Gene Expression Profiling , Humans , Leukemia, Promyelocytic, Acute/metabolism , Leukemia, Promyelocytic, Acute/pathology , Mice, Inbred C57BL , Mice, Inbred Strains , Mice, Nude , Mice, Transgenic , Oncogene Proteins, Fusion/metabolism , Oxides/pharmacology , Protein Binding , RNA Interference , Retinoid X Receptor alpha/genetics , Retinoid X Receptor alpha/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sumoylation , Transcriptional Activation/genetics , Tretinoin/pharmacology
18.
PLoS One ; 9(8): e104906, 2014.
Article in English | MEDLINE | ID: mdl-25119106

ABSTRACT

PML/RARA is the oncoprotein driving acute promyelocytic leukemia (APL). It suppresses genes expression by recruitment of a number of transcriptional repressors, resulting in differentiation block and malignant transformation of hematopoietic cells. Here, we found that mice primary hematopoietic progenitor cells (HPCs), transduced by DNA-binding-defective PML/RARA mutants, were deficient in colony formation. Further experiments showed that DNA-binding-defective PML/RARA mutants could not repress the transcription of retinoic acid regulated genes. Intriguingly, there were no significant differences of the micro-speckled intracellular distribution between the mutants and wild-type PML/RARA. Some retinoic acid target genes regulated by PML/RARA are involved in not only differentiation block but also hematopoietic cell self-renewal. Altogether, our data demonstrate that direct DNA-binding is essential for PML/RARA to immortalize hematopoietic cells, while disruption of PML-nuclear body does not seem to be a prerequisite for hematopoietic cell transformation.


Subject(s)
Cell Transformation, Neoplastic/genetics , Hematopoietic Stem Cells/pathology , Leukemia, Promyelocytic, Acute/genetics , Leukemia, Promyelocytic, Acute/pathology , Nuclear Proteins/genetics , Oncogene Proteins, Fusion/genetics , Receptors, Retinoic Acid/genetics , Transcription Factors/genetics , Tumor Suppressor Proteins/genetics , Animals , Cell Line , Cell Transformation, Neoplastic/metabolism , Cell Transformation, Neoplastic/pathology , Cells, Cultured , DNA/metabolism , Gene Expression Regulation, Leukemic , Hematopoietic Stem Cells/metabolism , Leukemia, Promyelocytic, Acute/metabolism , Mice , Mice, Inbred C57BL , Mutation , Nuclear Proteins/metabolism , Oncogene Proteins, Fusion/metabolism , Promyelocytic Leukemia Protein , Receptors, Retinoic Acid/metabolism , Retinoic Acid Receptor alpha , Transcription Factors/metabolism , Tretinoin/metabolism , Tumor Suppressor Proteins/metabolism
19.
Nat Commun ; 5: 4187, 2014 Jun 19.
Article in English | MEDLINE | ID: mdl-24942926

ABSTRACT

Small ubiquitin-related modifier (SUMO) protein conjugation onto target proteins regulates multiple cellular functions, including defence against pathogens, stemness and senescence. SUMO1 peptides are limiting in quantity and are thus mainly conjugated to high-affinity targets. Conjugation of SUMO2/3 paralogues is primarily stress inducible and may initiate target degradation. Here we demonstrate that the expression of SUMO1/2/3 is dramatically enhanced by interferons through an miRNA-based mechanism involving the Lin28/let-7 axis, a master regulator of stemness. Normal haematopoietic progenitors indeed display much higher SUMO contents than their differentiated progeny. Critically, SUMOs contribute to the antiviral effects of interferons against HSV1 or HIV. Promyelocytic leukemia (PML) nuclear bodies are interferon-induced domains, which facilitate sumoylation of a subset of targets. Our findings thus identify an integrated interferon-responsive PML/SUMO pathway that impedes viral replication by enhancing SUMO conjugation and possibly also modifying the repertoire of targets. Interferon-enhanced post-translational modifications may be essential for senescence or stem cell self-renewal, and initiate SUMO-dependent proteolysis.


Subject(s)
HIV-1/physiology , Herpesvirus 1, Human/physiology , MicroRNAs/immunology , RNA-Binding Proteins/immunology , SUMO-1 Protein/immunology , Small Ubiquitin-Related Modifier Proteins/immunology , Ubiquitins/immunology , HIV Infections/genetics , HIV Infections/immunology , HIV Infections/virology , HIV-1/genetics , Herpes Simplex/genetics , Herpes Simplex/immunology , Herpes Simplex/virology , Herpesvirus 1, Human/genetics , Humans , Interferons/immunology , MicroRNAs/genetics , RNA-Binding Proteins/genetics , SUMO-1 Protein/genetics , Small Ubiquitin-Related Modifier Proteins/genetics , Ubiquitins/genetics , Virus Replication
20.
J Exp Med ; 210(4): 647-53, 2013 Apr 08.
Article in English | MEDLINE | ID: mdl-23509325

ABSTRACT

In PML/RARA-driven acute promyelocytic leukemia (APL), retinoic acid (RA) induces leukemia cell differentiation and transiently clears the disease. Molecularly, RA activates PML/RARA-dependent transcription and also initiates its proteasome-mediated degradation. In contrast, arsenic, the other potent anti-APL therapy, only induces PML/RARA degradation by specifically targeting its PML moiety. The respective contributions of RA-triggered transcriptional activation and proteolysis to clinical response remain disputed. Here, we identify synthetic retinoids that potently activate RARA- or PML/RARA-dependent transcription, but fail to down-regulate RARA or PML/RARA protein levels. Similar to RA, these uncoupled retinoids elicit terminal differentiation, but unexpectedly fail to impair leukemia-initiating activity of PML/RARA-transformed cells ex vivo or in vivo. Accordingly, the survival benefit conferred by uncoupled retinoids in APL mice is dramatically lower than the one provided by RA. Differentiated APL blasts sorted from uncoupled retinoid-treated mice retain PML/RARA expression and reinitiate APL in secondary transplants. Thus, differentiation is insufficient for APL eradication, whereas PML/RARA loss is essential. These observations unify the modes of action of RA and arsenic and shed light on the potency of their combination in mice or patients.


Subject(s)
Antineoplastic Agents/pharmacology , Cell Differentiation/drug effects , Gene Expression Regulation, Leukemic/drug effects , Leukemia, Promyelocytic, Acute , Nuclear Proteins/metabolism , Proteolysis/drug effects , Receptors, Retinoic Acid/biosynthesis , Transcription Factors/metabolism , Transcriptional Activation/drug effects , Tretinoin/pharmacology , Tumor Suppressor Proteins/metabolism , Animals , Arsenic/pharmacology , Cell Differentiation/genetics , Cell Line , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/metabolism , Cell Transformation, Neoplastic/pathology , Humans , Leukemia, Promyelocytic, Acute/drug therapy , Leukemia, Promyelocytic, Acute/genetics , Leukemia, Promyelocytic, Acute/metabolism , Leukemia, Promyelocytic, Acute/pathology , Mice , Nuclear Proteins/genetics , Promyelocytic Leukemia Protein , Receptors, Retinoic Acid/genetics , Retinoic Acid Receptor alpha , Transcription Factors/genetics , Transcriptional Activation/genetics , Tumor Suppressor Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...